Found: 75
Select item for more details and to access through your institution.
Editorial: Autoantibodies for diagnostics, prognostics, and surveillance in autoimmune disease.
- Published in:
- Frontiers in Medicine, 2024, p. 1, doi. 10.3389/fmed.2024.1491035
- By:
- Publication type:
- Article
Abstract 167: COVID-19 vaccine side effects in Type 1 diabetes mellitus patients as compared to healthy controls: Results from the COVAD study.
- Published in:
- Indian Journal of Endocrinology & Metabolism, 2022, v. 26, p. 71, doi. 10.4103/2230-8210.363672
- By:
- Publication type:
- Article
B Cell Kinetics upon Therapy Commencement for Active Extrarenal Systemic Lupus Erythematosus in Relation to Development of Renal Flares: Results from Three Phase III Clinical Trials of Belimumab.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 13941, doi. 10.3390/ijms232213941
- By:
- Publication type:
- Article
Autoantibody and Cytokine Profiles during Treatment with Belimumab in Patients with Systemic Lupus Erythematosus.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 10, p. 3463, doi. 10.3390/ijms21103463
- By:
- Publication type:
- Article
A Comparison of the Correlation of Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K) and Systemic Lupus Erythematosus Disease Activity Score (SLE-DAS) with Health-Related Quality of Life.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 10, p. 2137, doi. 10.3390/jcm10102137
- By:
- Publication type:
- Article
Use of Antimalarial Agents Is Associated with Favourable Physical Functioning in Patients with Systemic Lupus Erythematosus.
- Published in:
- Journal of Clinical Medicine, 2020, v. 9, n. 6, p. 1813, doi. 10.3390/jcm9061813
- By:
- Publication type:
- Article
Editorial: Clinical, Molecular and Adverse Responses to B-Cell Therapies in Autoimmune Disease.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.962088
- By:
- Publication type:
- Article
Early B Cell and Plasma Cell Kinetics Upon Treatment Initiation Portend Flares in Systemic Lupus Erythematosus: A Post-Hoc Analysis of Three Phase III Clinical Trials of Belimumab.
- Published in:
- Frontiers in Immunology, 2022, v. 13, p. 1, doi. 10.3389/fimmu.2022.796508
- By:
- Publication type:
- Article
Type 1 diabetes, COVID‐19 vaccines and short‐term safety: Subgroup analysis from the global COVAD study.
- Published in:
- Journal of Diabetes Investigation, 2024, v. 15, n. 1, p. 131, doi. 10.1111/jdi.14079
- By:
- Publication type:
- Article
Treat-to-Target in Lupus Nephritis. What is the Role of the Repeat Kidney Biopsy?
- Published in:
- Archivum Immunologiae & Therapiae Experimentalis, 2022, v. 70, n. 1, p. 1, doi. 10.1007/s00005-022-00646-9
- By:
- Publication type:
- Article
COVID-19 Vaccination in Autoimmune Diseases (COVAD) study: Vaccine safety in idiopathic inflammatory myopathies.
- Published in:
- 2022
- By:
- Publication type:
- journal article
Clinical Reasoning Needs to Be Explicitly Addressed in Health Professions Curricula: Recommendations from a European Consortium.
- Published in:
- International Journal of Environmental Research & Public Health, 2021, v. 18, n. 21, p. 11202, doi. 10.3390/ijerph182111202
- By:
- Publication type:
- Article
Lifestyle interventions in the management of systemic sclerosis: a systematic review of the literature.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae037
- By:
- Publication type:
- Article
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey.
- Published in:
- Rheumatology Advances in Practice, 2024, v. 8, n. 2, p. 1, doi. 10.1093/rap/rkae028
- By:
- Publication type:
- Article
Factors Associated with Survival and Discontinuation of Anti-Malarial Agents in Systemic Lupus Erythematosus: Results from a Tertiary Swedish Referral Centre.
- Published in:
- Journal of Clinical Medicine, 2024, v. 13, n. 5, p. 1485, doi. 10.3390/jcm13051485
- By:
- Publication type:
- Article
B Cell Tolerance and Targeted Therapies in SLE.
- Published in:
- Journal of Clinical Medicine, 2023, v. 12, n. 19, p. 6268, doi. 10.3390/jcm12196268
- By:
- Publication type:
- Article
Intracardiac Thrombi in Morbus Adamantiades–Behçet in Two Swedish Patients.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Clinical Heterogeneity, Unmet Needs and Long-Term Outcomes in Patients with Systemic Lupus Erythematosus.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 22, p. 6869, doi. 10.3390/jcm11226869
- By:
- Publication type:
- Article
Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the Literature.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 19, p. 5759, doi. 10.3390/jcm11195759
- By:
- Publication type:
- Article
Low Serum BAFF Concentration Is Associated with Response to TNF Inhibitors in Seropositive Patients with Rheumatoid Arthritis.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 17, p. 5207, doi. 10.3390/jcm11175207
- By:
- Publication type:
- Article
How Can We Enhance Adherence to Medications in Patients with Systemic Lupus Erythematosus? Results from a Qualitative Study.
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 7, p. 1857, doi. 10.3390/jcm11071857
- By:
- Publication type:
- Article
Patient-Reported Outcomes in Systemic Lupus Erythematosus. Can Lupus Patients Take the Driver's Seat in Their Disease Monitoring?
- Published in:
- Journal of Clinical Medicine, 2022, v. 11, n. 2, p. 340, doi. 10.3390/jcm11020340
- By:
- Publication type:
- Article
Fatigue in Systemic Lupus Erythematosus and Rheumatoid Arthritis: A Comparison of Mechanisms, Measures and Management.
- Published in:
- Journal of Clinical Medicine, 2021, v. 10, n. 16, p. 3566, doi. 10.3390/jcm10163566
- By:
- Publication type:
- Article
Biomarkers in Neuropsychiatric Systemic Lupus Erythematosus: A Systematic Literature Review of the Last Decade.
- Published in:
- Brain Sciences (2076-3425), 2022, v. 12, n. 2, p. 192, doi. 10.3390/brainsci12020192
- By:
- Publication type:
- Article
Listening to patients, for the patients: The COVAD Study—Vision, organizational structure, and challenges.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 5, p. 1, doi. 10.1111/1756-185X.15161
- By:
- Publication type:
- Article
Flares of autoimmune rheumatic disease following COVID‐19 infection: Observations from the COVAD study.
- Published in:
- International Journal of Rheumatic Diseases, 2024, v. 27, n. 1, p. 1, doi. 10.1111/1756-185X.14961
- By:
- Publication type:
- Article
Pain in individuals with idiopathic inflammatory myopathies, other systemic autoimmune rheumatic diseases, and without rheumatic diseases: A report from the COVAD study.
- Published in:
- International Journal of Rheumatic Diseases, 2023, v. 26, n. 4, p. 727, doi. 10.1111/1756-185X.14636
- By:
- Publication type:
- Article
Serum profiling identifies CCL8, CXCL13, and IL-1RA as markers of active disease in patients with systemic lupus erythematosus.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1257085
- By:
- Publication type:
- Article
The Impact of Belimumab and Rituximab on Health-Related Quality of Life in Patients With Systemic Lupus Erythematosus.
- Published in:
- 2019
- By:
- Publication type:
- journal article
More Evidence on the Validity of the Measurement Properties of PROMIS Computerized Adaptive Tests in Systemic Lupus Erythematosus.
- Published in:
- Journal of Rheumatology, 2024, v. 51, n. 1, p. 4, doi. 10.3899/jrheum.2023-0947
- By:
- Publication type:
- Article
Patients with NPSLE experience poorer HRQoL and more fatigue than SLE patients with no neuropsychiatric involvement, irrespective of neuropsychiatric activity.
- Published in:
- Rheumatology, 2024, v. 63, n. 9, p. 2494, doi. 10.1093/rheumatology/keae216
- By:
- Publication type:
- Article
COVID-19 vaccine safety during pregnancy and breastfeeding in women with autoimmune diseases: results from the COVAD study.
- Published in:
- Rheumatology, 2024, v. 63, n. 5, p. 1341, doi. 10.1093/rheumatology/kead382
- By:
- Publication type:
- Article
Global disparities in the treatment of idiopathic inflammatory myopathies: results from an international online survey study.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 657, doi. 10.1093/rheumatology/kead250
- By:
- Publication type:
- Article
Determinants of neuropsychiatric flares in patients with systemic lupus erythematosus: results from five phase III trials of belimumab.
- Published in:
- Rheumatology, 2024, v. 63, n. 3, p. 798, doi. 10.1093/rheumatology/kead249
- By:
- Publication type:
- Article
Belimumab and antimalarials combined against renal flares in patients treated for extra-renal systemic lupus erythematosus: results from 4 phase III clinical trials.
- Published in:
- Rheumatology, 2024, v. 63, n. 2, p. 338, doi. 10.1093/rheumatology/kead253
- By:
- Publication type:
- Article
Flares in IIMs and the timeline following COVID-19 vaccination: a combined analysis of the COVAD-1 and -2 surveys.
- Published in:
- Rheumatology, 2024, v. 63, n. 1, p. 127, doi. 10.1093/rheumatology/kead180
- By:
- Publication type:
- Article
Flares in autoimmune rheumatic diseases in the post-COVID-19 vaccination period—a cross-sequential study based on COVAD surveys.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3838, doi. 10.1093/rheumatology/kead144
- By:
- Publication type:
- Article
Sensitivity analysis of EQ-5D-3L index scores in terms of discriminative and known-groups validity in SLE: introducing Adequate Health State.
- Published in:
- Rheumatology, 2023, v. 62, n. 12, p. 3916, doi. 10.1093/rheumatology/kead140
- By:
- Publication type:
- Article
Vaccine hesitancy decreases in rheumatic diseases, long-term concerns remain in myositis: a comparative analysis of the COVAD surveys.
- Published in:
- Rheumatology, 2023, v. 62, n. 10, p. 3291, doi. 10.1093/rheumatology/kead057
- By:
- Publication type:
- Article
Flares after COVID-19 infection in patients with idiopathic inflammatory myopathies: results from the COVAD study.
- Published in:
- Rheumatology, 2023, v. 62, n. 9, p. e263, doi. 10.1093/rheumatology/kead149
- By:
- Publication type:
- Article
COVID-19 vaccination in autoimmune diseases (COVAD) study: vaccine safety and tolerance in rheumatoid arthritis.
- Published in:
- Rheumatology, 2023, v. 62, n. 7, p. 2366, doi. 10.1093/rheumatology/keac624
- By:
- Publication type:
- Article
Impaired physical function in patients with idiopathic inflammatory myopathies: results from the multicentre COVAD patient-reported e-survey.
- Published in:
- Rheumatology, 2023, v. 62, n. 3, p. 1204, doi. 10.1093/rheumatology/keac441
- By:
- Publication type:
- Article
COVID-19 vaccination-related adverse events among autoimmune disease patients: results from the COVAD study.
- Published in:
- Rheumatology, 2023, v. 62, n. 1, p. 65, doi. 10.1093/rheumatology/keac305
- By:
- Publication type:
- Article
Impact of remission and low disease activity on health-related quality of life in patients with systemic lupus erythematosus.
- Published in:
- Rheumatology, 2022, v. 61, n. 12, p. 4752, doi. 10.1093/rheumatology/keac185
- By:
- Publication type:
- Article
EQ-5D-3L full health state discriminates between drug and placebo in clinical trials of systemic lupus erythematosus.
- Published in:
- Rheumatology, 2021, v. 60, n. 10, p. 4703, doi. 10.1093/rheumatology/keab080
- By:
- Publication type:
- Article
Contribution of abnormal BMI to adverse health-related quality of life outcomes after a 52-week therapy in patients with SLE.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4205, doi. 10.1093/rheumatology/keaa909
- By:
- Publication type:
- Article
De novo lupus nephritis during treatment with belimumab.
- Published in:
- Rheumatology, 2021, v. 60, n. 9, p. 4348, doi. 10.1093/rheumatology/keaa796
- By:
- Publication type:
- Article
Impact of overweight and obesity on patient-reported health-related quality of life in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2021, v. 60, n. 3, p. 1260, doi. 10.1093/rheumatology/keaa453
- By:
- Publication type:
- Article
ALCAM and VCAM-1 as urine biomarkers of activity and long-term renal outcome in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2020, v. 59, n. 9, p. 2237, doi. 10.1093/rheumatology/kez528
- By:
- Publication type:
- Article
Predictors of low disease activity and clinical remission following belimumab treatment in systemic lupus erythematosus.
- Published in:
- Rheumatology, 2019, v. 58, n. 12, p. 2170, doi. 10.1093/rheumatology/kez191
- By:
- Publication type:
- Article